Testing effectiveness (Phase 2)Active Not RecruitingNCT06093841
What this trial is testing
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
Who this might be right for
Lymphoma, Large B-Cell, DiffuseFollicular Lymphoma Grade 3BHigh-grade B-cell Lymphoma+1 more
Shanghai Ming Ju Biotechnology Co., Ltd. 46